MedPath

Effect of high-dose angiotensin II receptor blocker (ARB) monotherapy versus combination therapy of ARB with calcium channel blocker on vascular endothelial function in patients with essential hypertenso

Not Applicable
Conditions
essential hypertension
Registration Number
JPRN-UMIN000012538
Lead Sponsor
Osaka Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. History of ischemic heart disease 2. History of cerebrovascular disease 3. patients with renal dysfunction(serum creatinine greater than 1.5mg/dL) 4. patients with diabetes who are poor blood sugar control(HbA1c greater than8.0%) 5. By the change of antihypertensive drugs, blood pressure instability is suspected. 6. patients who takes high-dose ARB

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
vascular endothelial function
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath